- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07694960
Digital Technology Use, Digit Ratio, and Handgrip Strength in University Students (DTU-HGS)
July 5, 2026 updated by: Assoc. Prof. Dr. Özgür EKEN, Inonu University
Problematic Smartphone and Internet-Use Symptoms, Handgrip Strength, and Digit Ratio in University Students From Different Regional Backgrounds
This observational cross-sectional study examined associations among second-to-fourth digit ratio, handgrip strength, problematic smartphone-use symptoms, problematic Internet-use symptoms, and self-reported smartphone usage time in university students from different regional backgrounds.
The analytic sample included 173 students aged 17-26 years from Turkish, Middle Asian, African, and Asian regional backgrounds.
Participants completed validated self-report scales for smartphone-use and Internet-use symptoms, and underwent anthropometric, hand morphology, and handgrip strength measurements.
The study did not involve randomization, treatment assignment, intervention, or follow-up.
Study Overview
Status
Completed
Detailed Description
This exploratory observational cross-sectional study evaluated whether bilateral second-to-fourth digit ratio and handgrip strength were associated with smartphone-addiction symptom scores, Internet-addiction symptom scores, and self-reported smartphone usage time among university students from different regional backgrounds.
The final analytic sample consisted of 173 participants aged 17-26 years, including Turkish, Middle Asian, African, and Asian students.
Regional-background comparisons and sex-specific associations were analyzed using descriptive statistics, group comparisons, correlation analyses, and sensitivity analyses adjusted for age and body mass index.
The study was observational only and did not include any intervention, random allocation, treatment exposure, clinical procedure, or prospective follow-up.
Study Type
Observational
Enrollment (Actual)
173
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Balıkesir, Turkey (Türkiye)
- Bandırma Onyedi Eylül University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
University students aged 17-26 years from Turkish, Middle Asian, African, and Asian regional backgrounds studying at Bandırma Onyedi Eylül University.
Description
Inclusion Criteria:
- University students aged 17-26 years.
- Classifiable sex and regional-background information.
- Ability to understand the study procedures.
- Written informed consent provided.
- For participants younger than the legal age of majority, additional parent or legal guardian consent obtained according to institutional requirements.
Exclusion Criteria:
- Previous finger operation.
- Finger prosthesis.
- Median, radial, or ulnar nerve deformity.
- Carpal tunnel syndrome.
- Developmental or mental disorder preventing participation or valid assessment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Turkish university students
University students from Turkish regional background included in the observational cross-sectional analysis.
|
|
Middle Asian university students
University students from Middle Asian regional backgrounds included in the observational cross-sectional analysis.
|
|
African university students
University students from African regional backgrounds included in the observational cross-sectional analysis.
|
|
Asian university students
University students from Asian regional backgrounds included in the observational cross-sectional analysis.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Internet-addiction symptom score
Time Frame: At baseline / single cross-sectional assessment
|
Internet-addiction symptoms assessed using the Young Internet Addiction Scale-Short Form.
Higher scores indicate greater Internet-use symptom severity.
|
At baseline / single cross-sectional assessment
|
|
Smartphone-addiction symptom score
Time Frame: At baseline / single cross-sectional assessment
|
Smartphone-addiction symptoms assessed using the Smartphone Addiction Scale-Short Version.
Higher scores indicate greater smartphone-use symptom severity.
|
At baseline / single cross-sectional assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Second-to-fourth digit ratio
Time Frame: At baseline / single cross-sectional assessment
|
Right and left second-to-fourth digit ratios calculated from index and ring finger lengths measured using a digital caliper.
|
At baseline / single cross-sectional assessment
|
|
Handgrip strength
Time Frame: At baseline / single cross-sectional assessment
|
Right and left handgrip strength measured using an electronic handgrip dynamometer.
|
At baseline / single cross-sectional assessment
|
|
Self-reported smartphone usage time
Time Frame: At baseline / single cross-sectional assessment
|
Daily smartphone usage time reported by participants in hours per day.
|
At baseline / single cross-sectional assessment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2022
Primary Completion (Actual)
May 30, 2023
Study Completion (Actual)
May 30, 2023
Study Registration Dates
First Submitted
July 5, 2026
First Submitted That Met QC Criteria
July 5, 2026
First Posted (Actual)
July 10, 2026
Study Record Updates
Last Update Posted (Actual)
July 10, 2026
Last Update Submitted That Met QC Criteria
July 5, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BYEU-HSI-2022-164
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be publicly shared because the dataset contains participant-level behavioral and anthropometric information.
Data may be available from the corresponding author upon reasonable request and subject to ethical and institutional approval.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteers
-
AstraZenecaCompletedHealthy Elderly Volunteers | Healthy Young VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
Syndax PharmaceuticalsCompletedHealthy Volunteers | Volunteers | Normal Volunteers | Human VolunteersUnited States
-
University Hospital, Clermont-FerrandUnite de Nutrition Humaine UMR 1019- INRAE; Unite MetaGenoPolis INRAE; France...CompletedHealthy Volunteers | Frail VolunteersFrance
-
Newcastle UniversityCompletedGI Glycaemic Index Healthy Volunteers | GL Glycaemic Load Healthy VolunteersUnited Kingdom
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
Galera Therapeutics, Inc.CelerionCompletedHealthy | Healthy VolunteersUnited States
-
Danone NutriciaCompletedHealthy Elderly | Healthy VolunteersChina
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands